Cynosure Introduces Affirm(TM) Skin Rejuvenation Device
February 08 2006 - 7:30AM
PR Newswire (US)
Multi-Energy Light-Based System Supports Multiple High-Volume
Applications WESTFORD, Mass., Feb. 8 /PRNewswire-FirstCall/ --
Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer
of lasers and pulsed light sources, today announced the
introduction of its new Affirm(TM) product, a multi-energy system
for skin rejuvenation, including treatments for wrinkles, skin
texture and discoloration. The Affirm system, which recently
received FDA clearance, will be introduced at the American Academy
of Dermatology (AAD) conference in San Francisco, March 3-7, 2006
and will be launched at the American Society of Lasers in Medicine
and Surgery (ASLMS) conference, which is being held April 7-9,
2006. The Affirm system has been designed to bring greater
flexibility to physician practices by supporting a diverse range of
high-volume skin rejuvenation applications. Utilizing a proprietary
delivery system, the Affirm product is the first system to combine
multiple energy sources in one platform to provide treatment for
wrinkles, micro-rejuvenation and skin discoloration. "We are
delighted to introduce an exciting new product to this under-
served segment of the market," said Michael R. Davin, Chairman and
CEO of Cynosure, Inc. "Given its advanced capabilities and the
growing demand for anti-aging products, we believe the Affirm laser
system has the potential to become an important product for
Cynosure in the quarters and years ahead." Robert A. Weiss, MD of
the Laser Skin & Vein Institute, Baltimore, MD will present a
clinical lecture at the AAD meeting on March 6, 2006, entitled
"Microfocussing Techniques of Non-Ablative Lasers for Wrinkling and
Scar Collagen Remodeling." The lecture will discuss the clinical
application of the Affirm system for the treatment of mild facial
wrinkles, depressed acne scars and photo aging of the chest, neck
and other extremities such as the hands and legs. Additional
clinical findings relating to the use of the Affirm system will be
presented in the form of four presentation abstracts that have been
accepted for the upcoming ASLMS conference April 7-9, 2006 in
Boston. About Cynosure, Inc. Cynosure, Inc. develops and markets
aesthetic treatment systems that are used by physicians and other
practitioners to perform non-invasive procedures to remove hair,
treat vascular lesions, rejuvenate skin through the treatment of
shallow vascular and pigmented lesions and temporarily reduce the
appearance of cellulite. Cynosure's products include a broad range
of laser and other light-based energy sources, including
Alexandrite, pulse-dye, Nd:YAG and diode lasers, as well as intense
pulsed light. Cynosure was founded in 1991. For corporate or
product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosurelaser.com/. Any statements in this press release
about future expectations, plans and prospects for Cynosure, Inc.,
including statements about the timing and financial impact of
product launches, as well as other statements containing the words
"believes," "anticipates," "plans," "expects," "will," and similar
expressions, constitute forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by such
forward-looking statements as a result of various important
factors, including risks and uncertainties of market acceptance of
and demand for the Affirm(TM) system by providers of aesthetic
procedures and their patients and clients, Cynosure's history of
operating losses, its reliance on sole source suppliers,
competition in the aesthetic laser industry, economic, market,
technological and other factors discussed in Cynosure's
Registration Statement on Form S-1, as amended, filed with the SEC.
In addition, the forward-looking statements included in this press
release represent Cynosure's views as of the date of this press
release. Cynosure anticipates that subsequent events and
developments will cause its views to change. However, while
Cynosure may elect to update these forward-looking statements at
some point in the future, it specifically disclaims any obligation
to do so. These forward-looking statements should not be relied
upon as representing Cynosure's views as of any date subsequent to
the date of this press release. Contact: Timothy Baker 800-886-2966
First Call Analyst: FCMN Contact: DATASOURCE: Cynosure, Inc.
CONTACT: Timothy Baker of Cynosure, Inc., +1-800-886-2966, Web
site: http://www.cynosurelaser.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024